Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Genetic Technologies Sponsored ADR Representing 30 Ord Shs GENE

Technology Scientific & Technical Instruments
Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its geneType and EasyDNA brands. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a... see more

Recent & Breaking News (NDAQ:GENE)

Genetic Technologies' COVID-19 Risk Test Approved for Commercial Release

GlobeNewswire April 26, 2021

Genetic Technologies appoints Mike Tonroe as CFO

GlobeNewswire April 12, 2021

Genetic Technologies Provides Update on COVID-19 Risk Test Launch

GlobeNewswire April 9, 2021

Genetic Technologies Signs Multi-Year US Distribution Agreement for COVID Risk Test

GlobeNewswire March 4, 2021

Genetic Technologies Limited Interview to Air on Bloomberg TV in the US on the RedChip Money Report®

GlobeNewswire February 26, 2021

Genetic Technologies Announces Closing of $6.56 Million Registered Direct Offering

GlobeNewswire January 25, 2021

Genetic Technologies Announces $6.56 Million Registered Direct Offering

GlobeNewswire January 21, 2021

Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing

GlobeNewswire January 21, 2021

Genetic Technologies Secures US and ANZ Distribution Rights for PREDICTIX

GlobeNewswire December 2, 2020

Genetic Technologies Interview Aired on Bloomberg International on the RedChip Money Report

GlobeNewswire November 23, 2020

Genetic Technologies to Hold Investor Webinar and Q&A Session on November 19

GlobeNewswire November 17, 2020

Genetic Technologies Provides Update on COVID-19 Risk Test

GlobeNewswire October 1, 2020

Genetic Technologies Provides Update on COVID-19 Disease Severity Test Development

GlobeNewswire September 15, 2020

Genetic Technologies Announces US Sales Have Commenced via Online Health Platform

GlobeNewswire September 11, 2020

Genetic Technologies Regains Compliance with Nasdaq Stockholders Equity Requirement

GlobeNewswire September 1, 2020

Genetic Technologies Announces Closing of $5.1 Million Registered Direct Offering

GlobeNewswire July 20, 2020

Genetic Technologies Announces $5.1 Million Registered Direct Offering

GlobeNewswire July 16, 2020

Genetic Technologies Provides Update on COVID-19 Disease Severity Test

GlobeNewswire July 15, 2020

Genetic Technologies CEO to Participate in Investor Webinar and Q&A Session on June 24, 2020

GlobeNewswire June 23, 2020

US Patent Office Grants Key Risk Test Patent

GlobeNewswire June 18, 2020